BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31785246)

  • 1. Influence of the CB
    Poleszak E; Wośko S; Sławińska K; Wyska E; Szopa A; Świąder K; Wróbel A; Doboszewska U; Wlaź P; Wlaź A; Serefko A
    Pharmacol Biochem Behav; 2020 Jan; 188():172833. PubMed ID: 31785246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligands of the CB2 cannabinoid receptors augment activity of the conventional antidepressant drugs in the behavioural tests in mice.
    Poleszak E; Wośko S; Sławińska K; Wyska E; Szopa A; Sobczyński J; Wróbel A; Doboszewska U; Wlaź P; Wlaź A; Szponar J; Skałecki P; Serefko A
    Behav Brain Res; 2020 Jan; 378():112297. PubMed ID: 31626848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CB
    Wośko S; Serefko A; Szopa A; Wlaź P; Wróbel A; Wlaź A; Górska J; Poleszak E
    J Pharm Pharmacol; 2018 Apr; 70(4):566-575. PubMed ID: 29380383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agomelatine and tianeptine antidepressant activity in mice behavioral despair tests is enhanced by DMPX, a selective adenosine A
    Szopa A; Bogatko K; Serefko A; Wyska E; Wośko S; Świąder K; Doboszewska U; Wlaź A; Wróbel A; Wlaź P; Dudka J; Poleszak E
    Pharmacol Rep; 2019 Aug; 71(4):676-681. PubMed ID: 31200233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the CB
    Poleszak E; Wośko S; Sławińska K; Wyska E; Szopa A; Doboszewska U; Wlaź P; Wlaź A; Dudka J; Szponar J; Serefko A
    Brain Res Bull; 2019 Aug; 150():179-185. PubMed ID: 31158462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system.
    Kruk-Slomka M; Michalak A; Biala G
    Behav Brain Res; 2015 May; 284():24-36. PubMed ID: 25660201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traxoprodil augments the antidepressant-like activity of agomelatine but not of mianserin or tianeptine in the forced swim test in mice.
    Stasiuk W; Serefko A; Szopa A; Wyska E; Świąder K; Wlaź P; Poleszak E
    Pharmacol Rep; 2016 Oct; 68(5):960-3. PubMed ID: 27371898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine-induced antidepressant like effects in mice: A possible involvement of cannabinoid system.
    Khakpai F; Ebrahimi-Ghiri M; Alijanpour S; Zarrindast MR
    Biomed Pharmacother; 2019 Apr; 112():108717. PubMed ID: 30970516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice.
    Wlaź P; Kasperek R; Wlaź A; Szumiło M; Wróbel A; Nowak G; Poleszak E
    Pharmacol Rep; 2011; 63(6):1526-32. PubMed ID: 22358100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of antidepressant effects of venlafaxine by agomelatine in mice are independent of kynurenine pathway.
    Thomas J; Khanam R; Vohora D
    Neurochem Int; 2016 Oct; 99():103-109. PubMed ID: 27311540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors.
    Hayase T
    BMC Pharmacol; 2011 Jul; 11():6. PubMed ID: 21767384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid CB
    Weresa J; Pędzińska-Betiuk A; Kossakowski R; Malinowska B
    Pharmacol Rep; 2019 Feb; 71(1):82-89. PubMed ID: 30500553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice.
    Poleszak E; Wośko S; Sławińska K; Wyska E; Szopa A; Świąder K; Wróbel A; Szponar J; Doboszewska U; Wlaź P; Wlaź A; Serefko A
    Pharmacol Rep; 2020 Dec; 72(6):1562-1572. PubMed ID: 32221841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice.
    Ostadhadi S; Haj-Mirzaian A; Nikoui V; Kordjazy N; Dehpour AR
    Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):203-12. PubMed ID: 26609670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid CB
    Olianas MC; Dedoni S; Onali P
    Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.
    Bi GH; Galaj E; He Y; Xi ZX
    Addict Biol; 2020 Jul; 25(4):e12783. PubMed ID: 31215752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption.
    Onaivi ES; Carpio O; Ishiguro H; Schanz N; Uhl GR; Benno R
    Ann N Y Acad Sci; 2008 Oct; 1139():426-33. PubMed ID: 18991890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antidepressant-like effect of citicoline and CB 1 agonist in male mice.
    Amanzade A; Khakpai F; Zarrindast MR
    Psychopharmacology (Berl); 2024 Apr; 241(4):753-766. PubMed ID: 38383902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-Like Activity of Typical Antidepressant Drugs in the Forced Swim Test and Tail Suspension Test in Mice Is Augmented by DMPX, an Adenosine A
    Poleszak E; Szopa A; Bogatko K; Wyska E; Wośko S; Świąder K; Doboszewska U; Wlaź A; Wróbel A; Wlaź P; Serefko A
    Neurotox Res; 2019 Feb; 35(2):344-352. PubMed ID: 30267268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test.
    Hill MN; Gorzalka BB
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):593-9. PubMed ID: 15916883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.